← Back
SAN FREDIANO
December, 05th | 15:00 - 15:45
FREE PAPERS - HIGHLIGHTED NEW DRUGS AMD 2
Add to calendar
Chairs: CHAKRAVARTHY USHA, HEIER JEFFREY S., HO ALLEN
December, 05th | 15:00 - 15:03
Subretinal delivery of investigational abbv-rgx-314 for neovascular age-related macular degeneration (NAMD): a phase ii pharmacodynamic study
STANGA PAULO EDUARDO
Add to calendar
Subretinal delivery of investigational abbv-rgx-314 for neovascular age-related macular degeneration (NAMD): a phase ii pharmacodynamic study
STANGA PAULO EDUARDO
Add to calendar
December, 05th | 15:03 - 15:06
Subretinal delivery of investigational abbv-rgx-314 as a gene therapy for neovascular age-related macular degeneration (NAMD): interim results of bilateral dosing from a fellow eye study
HO ALLEN
Add to calendar
Subretinal delivery of investigational abbv-rgx-314 as a gene therapy for neovascular age-related macular degeneration (NAMD): interim results of bilateral dosing from a fellow eye study
HO ALLEN
Add to calendar
December, 05th | 15:06 - 15:09
EYP-1901 (vorolanib intravitreal insert), a bioerodible, sustained-delivery intravitreal insert for neovascular age-related macular degeneration: preclinical development to pivotal phase 3 trials
CHAKRAVARTHY USHA
Add to calendar
EYP-1901 (vorolanib intravitreal insert), a bioerodible, sustained-delivery intravitreal insert for neovascular age-related macular degeneration: preclinical development to pivotal phase 3 trials
CHAKRAVARTHY USHA
Add to calendar
December, 05th | 15:09 - 15:12
Ixoberogene soroparvovec (ixo-vec) intravitreal gene therapy for neovascular age-related macular degeneration: phase 2 luna study update
WYKOFF CHARLES C.
Add to calendar
Ixoberogene soroparvovec (ixo-vec) intravitreal gene therapy for neovascular age-related macular degeneration: phase 2 luna study update
WYKOFF CHARLES C.
Add to calendar
December, 05th | 15:12 - 15:15
Unlocking structure/function relationships in dry AMD/GA: central subdomain preservation and visual acuity protection with c1q inhibition
HEIER JEFFREY S.
Add to calendar
Unlocking structure/function relationships in dry AMD/GA: central subdomain preservation and visual acuity protection with c1q inhibition
HEIER JEFFREY S.
Add to calendar
December, 05th | 15:15 - 15:18
Post-marketing data support a differentiated safety profile of avacincaptad pegol (acp) for geographic atrophy (GA) secondary to AMD
ALMEIDA DAVID
Add to calendar
Post-marketing data support a differentiated safety profile of avacincaptad pegol (acp) for geographic atrophy (GA) secondary to AMD
ALMEIDA DAVID
Add to calendar
December, 05th | 15:18 - 15:21
Reduction in risk probability of persistent vision loss with avacincaptad pegol in geographic atrophy: 2-year results from the gather2 trial
KUPPERMANN BARUCH
Add to calendar
Reduction in risk probability of persistent vision loss with avacincaptad pegol in geographic atrophy: 2-year results from the gather2 trial
KUPPERMANN BARUCH
Add to calendar
December, 05th | 15:21 - 15:24
Prevention of visual acuity loss and preservation of photoreceptors by anx007 in dry age-related macular degeneration (AMD)/geographic atrophy (ga) in the phase 2 archer trial, including in patients with less advanced disease
STANGA PAULO EDUARDO
Add to calendar
Prevention of visual acuity loss and preservation of photoreceptors by anx007 in dry age-related macular degeneration (AMD)/geographic atrophy (ga) in the phase 2 archer trial, including in patients with less advanced disease
STANGA PAULO EDUARDO
Add to calendar
December, 05th | 15:24 - 15:27
Ophthalmic Iontophoresis treatment for topical delivery of lutein, Slowing/preventing Progression of AMD
ZUCCARINI SILVIO
Add to calendar
Ophthalmic Iontophoresis treatment for topical delivery of lutein, Slowing/preventing Progression of AMD
ZUCCARINI SILVIO
Add to calendar